CLINUVEL implements strategic reorganisation to refocus on U.S. market 2026 Announcements.Corporate.News.Regulatory 23.07.2026
Only part of the story: why we likely need more than immune suppression to treat vitiligo Vitiligo Hub 22.07.2026
CLINUVEL’s ADS commences trading on Nasdaq 2026 Announcements . Corporate . News . Regulatory 21.07.2026
CLINUVEL’s ADS to commence trading on Nasdaq 2026 Announcements . Corporate . News . Regulatory 20.07.2026
CLINUVEL confirms terms of CEO’s Employment Agreement 2026 Announcements . Corporate . News 02.07.2026
CLINUVEL publicly files 20-F Registration Statement to U.S. SEC 2026 Announcements . Corporate . Financial . News . Regulatory 16.06.2026
CLINUVEL non-deal roadshow presentation deck 2026 Announcements . Corporate . News . Presentation 02.06.2026
Appendix 3G — Notification on unquoted securities 2026 Announcements . Financial . News . Regulatory 07.05.2026
CLINUVEL: update on Level II ADR upgrade, Nasdaq uplist 2026 Announcements . Clinical . News 28.04.2026